For the first time, the U.S. Food and Drug Administration (FDA) has approved the use of a ketamine-like drug as a stand-alone therapy for adults with treatment-resistant depression (TRD).

The FDA has approved Janssen’s antidepressant ... who have cycled through multiple treatments without relief. Spravato (esketamine) has been touted as a potential blockbuster for Janssen ...

Alert FDA OKs Esketamine Nasal Spray Monotherapy for Depression The expanded indication allows esketamine nasal spray to be used as a standalone treatment in adults with MDD who have not responded ...

Janssen’s potential depression treatment made from esketamine – a version of the substance notoriously used illegally as a party drug – is to be reviewed by advisers to the FDA at a crunch ...

This is because the Food and Drug Administration (FDA) only approves the drug ketamine for use in general anesthetics. However, Medicare may cover the drug Spravato, which contains esketamine.

In terms of the newest collaboration, the health care professionals said they decided that having all the services under one ...

It wasn’t long before a new word was bandied about: breakthrough. In 2013, the U.S. Food and Drug Administration (FDA) granted esketamine a “Breakthrough Therapy Designation” to accelerate studies of ...

The FDA has given marketing authorization to Zyn nicotine pouches. That doesn't necessarily mean they're safe to use, especially for young people, and experts say there's little evidence that they ...

There is hope for your symptoms. The clinic also offer the FDA approved Spravato (Esketamine) for treatment resistant depression, anxiety, and PTSD. Call for inquiries. Immediate appointment times ...

TMS is a local treatment, has no systemic side effects, and is FDA-approved for treatment resistant depression and OCD. Esketamine, branded as Spravato, is a nasal spray that works on different ...